Vitexin causes the phosphorylation of PI3K, AKT, and mTOR and decreases the expression of HIF-1α, implying that Vitexin inhibits the activation of the PI3K/AKT/mTOR/HIF-1α pathway and thus prevents the EMT of GC cells. The gene discussed is MTOR; the disease is gastric cancer.